Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Device company Entellus Medical nets $37.6mm in FOPO

Executive Summary

Entellus Medical Inc. netted $37.6mm through the sale of 2.35mm common shares at $17 in a follow-on public offering. Selling shareholders also sold 1.2mm common shares. The company, which focuses on minimally invasive treatment of chronic and recurrent sinusitis, will use the offering proceeds for working capital and to repay part of its outstanding credit facility with Oxford Finance.
Deal Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies

Advertisement
UsernamePublicRestriction

Register